Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group Announces Upcoming Presentation to Release 48-Week Data from Phase I Clinical Trial for AlloJoin™ Off-the-Shelf Allogeneic Stem Cell Therapy for Knee Osteoarthritis
March 14, 2018 07:30 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group Reports Full-Year 2017 Financial Results and Recent Operational Progress
March 06, 2018 09:27 ET | Cellular Biomedicine Group Inc.
  Expanded GMP manufacturing capacity to become one of the largest in-house CAR-T manufacturers amongst leading global biopharmaceutical companiesSigned partnerships with GE Healthcare Life Sciences...
Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group Invited to Present a Keynote Speech at Phar-East Asia Pharma & Biotech Festival
March 01, 2018 09:15 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a biomedicine firm engaged in the development of...
Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group Announces $30.6 million Investment from Sailing Capital Overseas Investment Ltd.
February 05, 2018 08:18 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development...
CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution 
January 19, 2018 20:43 ET | Cellular Biomedicine Group Inc.
GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercializationFirst GE Healthcare FlexFactory™ for cell therapy installation in...
医疗全新一站式解决方案助力西比曼加速细胞治疗药物生产
January 19, 2018 20:43 ET | Cellular Biomedicine Group Inc.
GE为西比曼加速CAR-T细胞治疗药物的临床试验及未来商业化进程提供生产支持西比曼上海工厂将成为全球首个采用GE医疗细胞治疗灵活生产平台(FlexFactoryTM)技术的细胞治疗产品生产设施,并配备功能完善且可扩展的细胞治疗生产能力、培训及服务 中国上海及美国加州库比蒂诺市, Jan. 20, 2018 (GLOBE NEWSWIRE) --...
CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution 
January 18, 2018 16:15 ET | Cellular Biomedicine Group Inc.
GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercialization First GE Healthcare FlexFactory™ for cell therapy installation...
Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group Announces Closing of $14.5 Million Private Placement Offering
December 28, 2017 07:30 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Operational Highlights
November 09, 2017 08:30 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical company engaged...
Cellular Biomedicine Group Opens its New Shanghai GMP Facility and Joint Laboratory
November 07, 2017 06:00 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...